Results for hepatitis translation from French to Danish

hepatitis c
- oprindelse

hépatite a (hepatitis epidemica)
hepatitis a (hepatitis epidemica)

l03 treatment of chronic hepatitis c
l03 treatment of chronic hepatitis c

ils mettent de l' "hepatitis v"
de har smittet vores tru-blood med hepatitis v.

jo5af05 treatment of chronic hepatitis b
jo5af05 treatment of chronic hepatitis b

hepacare triple antigen hepatitis b vaccine
04. 08. 2000

l03ab05 treatment of chronic hepatitis b and c
l03ab05 treatment of chronic hepatitis b and c

l03ab11 treatment of chronic hepatitis c in adults
l03ab11 treatment of chronic hepatitis c in adults

j07bc immunisation against hepatitis b virus in adults
prophylaxis of bleeding in haemophilia a

procomvax haemophilus b conjugate and hepatitis b vaccine part a
procomvax haemophilus b conjugate and hepatitis b vaccine part a

j05 (pending) treatment of chronic hepatitis b in adults
j05 (pending) treatment of chronic hepatitis b in adults

j05ab04 treatment in combination with interferon alpha 2b of chronic hepatitis c
j05ab04 treatment in combination with interferon alpha 2b

recombinant hepatitis b virus small surface antigen (hbsag) part a
recombinant hepatitis b virus small surface antigen (hbsag) part a

j07ca immunisation against haemophilus influenzae type b and infection by hepatitis b virus in infants
j07ca immunisation against haemophilus influenzae type b and infection by hepatitis b virus in infants

active immunisation against hepatitis b virus infection caused by all known subtypes in children and adolescents
active immunisation against hepatitis b virus infection caused by all known subtypes in children and adolescents

suspension for injection haemophilus influenzae type b 7.5 µg n. meningitidis ompc 125 µg recombinant hepatitis b surface antigen 5 µg 1 presentation
suspension for injection haemophilus influenzae type b 7. 5 µg n. meningitidis ompc 125 µg recombinant hepatitis b surface antigen 5 µg 1 presentation

l03ab05 treatment of chronic hepatitis b and c, hairy cell leukaemia, chronic myelogenous leukaemia, multiple myeloma, follicular lymphoma, carcinoid tumors and malignant melanoma
hairy cell leukaemia, chronic myelogenous leukaemia, multiple myeloma, follicular lymphoma, carcinoid tumors and malignant melanoma

core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)